NEW YORK – Illumina's core next-generation sequencing business is set to grow again, thanks to strong sales of its high-throughput NovaSeq instruments and reagents and due to growing business in China.
NEW YORK – Illumina's core next-generation sequencing business is set to grow again, thanks to strong sales of its high-throughput NovaSeq instruments and reagents and due to growing business in China.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.